Baixar PDF
Artigo anterior
Voltar à página
Artigo seguinte
If you have problems to see the content please click here
Outros usuários também visualizaram estes artigos
Brazilian chronic myeloid leukemia working group recommendations for discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia in clinical practice
Carla Boquimpani; Fernanda Salles Seguro; Gustavo Henrique Romani Magalhães; Ingrid Luise Soares Pinto; Israel Bendit; Jaisson André Pagnoncelli Bortolini; Katia Borgia Barbosa Pagnano; Renato Centrone; Vaneuza Funke;
Hematol Transfus Cell Ther. 2022;44:402-9
Epidemiological characterization of chronic myeloid leukaemia patients at an oncologic centre: A retrospective observational study
Ana Maria Meireles; Rita Calisto; Maria José Bento; Pedro Martinho Gouveia; Susana Bizarro; Manuel Teixeira; Cláudia Moreira; Ana Espírito Santo; Mário Mariz;
10.1016/j.htct.2025.103935
Recommendations for the management of cardiovascular risk in patients with chronic myeloid leukemia on tyrosine kinase inhibitors: risk assessment, stratification, treatment and monitoring
Fernanda Salles Seguro; Carolina Maria Pinto Domingues Carvalho Silva; Carla Maria Boquimpani de Moura; Monika Conchon; Laura Fogliatto; Vaneuza Araujo Moreira Funke; André Abdo; Ariane Vieira Scarlatelli Macedo; Marilia Harumi Higushi dos Santos; José Francisco Kerr Saraiva;
Hematol Transfus Cell Ther. 2021;43:191-200